Study Name: Treating Suicidal Behavior and Self-Mutilation in BPD: Predictors of Change
Principal Investigator: Barbara Stanley, Ph.D.
Purpose of Study: This study is a randomized controlled treatment study comparing the efficacy of 6-months of Dialectical Behavior Therapy to 6-months of SSRI antidepressant medication/supportive clinical management in reducing suicidal and self-injurious behavior in individuals who suffer from borderline personality disorder (BPD). Patients also undergo MRI scans before and after treatment.
Treatment Offered: 6 months of either Dialectical Behavior Therapy (DBT) or SSRI medication/supportive clinical management. Patients who are randomized to and complete the 6 months of SSRI medication treatment are offered an additional 6 months of DBT treatment in our clinic followed by referral to ongoing care.
Eligibility: Diagnosis of Borderline Personality Disorder with recent suicidal and/or self-injurious behaviors; 18-65 years old.
Funding: NIMH R01 MH061017
Contact Information: Emily Biggs, M.A.